Literature DB >> 2576000

Effects of seganserin, a 5-HT2 antagonist, and temazepam on human sleep stages and EEG power spectra.

D J Dijk1, D G Beersma, S Daan, R H van den Hoofdakker.   

Abstract

The effects of seganserin, a specific 5HT2 antagonist, on human sleep were assessed in two experiments and compared to the effects of temazepam and sleep deprivation. During daytime recovery sleep after sleep deprivation, seganserin did not significantly enhance visually scored slow wave sleep (SWS, stages 3 + 4) or the EEG power density in the delta frequencies. Under these conditions temazepam reduced the power density in the delta and theta frequencies. During nighttime sleep after a nap in the evening, seganserin caused an increase in SWS, a reduction in intermittent wakefulness, and an enhancement of the power density in the delta and theta frequencies during non-rapid eye movement (NREM) sleep. Temazepam induced a reduction in the power density in the delta and theta frequencies. It is concluded that the 5HT2 antagonist, seganserin, can induce SWS. However, since the spectral results showed that the changes in the sleep EEG were not identical to those induced by sleep deprivation it seems premature to conclude that 5HT2 receptors are primarily involved in NREM sleep regulation.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2576000     DOI: 10.1016/0014-2999(89)90109-x

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  21 in total

1.  Can an inert sleeping pill affect sleep? Effects on polysomnographic, behavioral and subjective measures.

Authors:  Fabiana Fratello; Giuseppe Curcio; Michele Ferrara; Cristina Marzano; Alessandro Couyoumdjian; Giovanna Petrillo; Mario Bertini; Luigi De Gennaro
Journal:  Psychopharmacology (Berl)       Date:  2005-09-29       Impact factor: 4.530

Review 2.  Hypnotics and sleep physiology: a consensus report. European Sleep Research Society, Committee on Hypnotics and Sleep Physiology.

Authors:  A A Borbély; T Akerstedt; O Benoit; F Holsboer; I Oswald
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  1991       Impact factor: 5.270

3.  Effects of olanzapine, risperidone and haloperidol on sleep after a single oral morning dose in healthy volunteers.

Authors:  Sandra Giménez; Susana Clos; Sergio Romero; Eva Grasa; Adelaida Morte; Manuel J Barbanoj
Journal:  Psychopharmacology (Berl)       Date:  2007-01-05       Impact factor: 4.530

4.  Effect of zolpidem on sleep and sleep EEG spectra in healthy young men.

Authors:  D P Brunner; D J Dijk; M Münch; A A Borbély
Journal:  Psychopharmacology (Berl)       Date:  1991       Impact factor: 4.530

Review 5.  Regulation and functional correlates of slow wave sleep.

Authors:  Derk-Jan Dijk
Journal:  J Clin Sleep Med       Date:  2009-04-15       Impact factor: 4.062

Review 6.  Sleep abnormalities during abstinence in alcohol-dependent patients. Aetiology and management.

Authors:  H P Landolt; J C Gillin
Journal:  CNS Drugs       Date:  2001       Impact factor: 5.749

Review 7.  Sleep as a Therapeutic Target in the Aging Brain.

Authors:  Thierno M Bah; James Goodman; Jeffrey J Iliff
Journal:  Neurotherapeutics       Date:  2019-07       Impact factor: 7.620

8.  Effect of gaboxadol on sleep in adult and elderly patients with primary insomnia: results from two randomized, placebo-controlled, 30-night polysomnography studies.

Authors:  D Alan Lankford; Bruce C Corser; Yan-Ping Zheng; Zhengrong Li; Duane B Snavely; Christopher R Lines; Steve Deacon
Journal:  Sleep       Date:  2008-10       Impact factor: 5.849

9.  Bretazenil modulates sleep EEG and nocturnal hormone secretion in normal men.

Authors:  J Guldner; L Trachsel; C Kratschmayr; B Rothe; F Holsboer; A Steiger
Journal:  Psychopharmacology (Berl)       Date:  1995-11       Impact factor: 4.530

10.  Increased wakefulness, motor activity and decreased theta activity after blockade of the 5-HT2B receptor by the subtype-selective antagonist SB-215505.

Authors:  Sandor Kantor; Rita Jakus; Brigitta Balogh; Anita Benko; Gyorgy Bagdy
Journal:  Br J Pharmacol       Date:  2004-07-20       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.